Vertigo
assessement within reach
Vesti is a MedTech Research to Business (R2B) project which aims to lead vertigo assessment to a new era by introducing a novel diagnostic tool.
vesti.
Vertigo assessment today
1
Vertigo and dizziness are the cause of 14.3% of all outpatient visits in the US.​
Kovacs et al. Health Economics Review 2019
2
“Many dizzy patients remain undiagnosed even after a thorough examination, highlighting the challenges faced by Primary Care Physicians and potentially leading to frequent referrals to specialists.“
Zwergal A. et al Front Neurol. 2023
3
Cost burden of episodic vestibular disorders ($151B in the US) are higher than nearly any chronic disease
Jeong SS et al. JAMA Otolaryngol Head Neck Surg. 2022
Our focus
Vesti technology will improve the access to accurate vertigo assessment and reduce extraneous imaging orders and other healthcare resources and patients' work absenteeism. We expect the new technology to improve the patient journey and quality of life and to disrupt the current vestibular diagnostic market.
​
Vesti R2B is funded by Business Finland and Aalto University
Unique team born at
Our human-centered way to develop diagnostic solution addresses issues in the multi-layer human network from patients to procurement. Our team is dedicated to creating global health impact and smarter use of healthcare resources.
Dr. Janita Nissi, Technology Expert, D.Sc. Electrical Engineering
Otto Kangasmaa, Technology Expert, M.Sc. Electrical Engineering
Ida Koho, Business Developer, B Sc. Biotech Engineering, MBA
Prof. Ilkka Laakso, Principal Investigator, D.Sc. Electrical Engineering
Henriikka Halinen, Senior Advisor, B.Sc. Biomed Engineering, M.Sc. Computer Sciences